{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:01:08Z","timestamp":1761919268420},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2010,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1111\/j.1478-3231.2009.02168.x","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T08:49:12Z","timestamp":1258015752000},"page":"396-405","source":"Crossref","is-referenced-by-count":5,"title":["Hepadnaviral infection augments hepatocyte cytotoxicity mediated by both CD95 ligand and perforin pathways"],"prefix":"10.1111","volume":"30","author":[{"given":"Clifford S.","family":"Guy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz I.","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB1","doi-asserted-by":"crossref","unstructured":"1.\u2002 Racanelli V , Rehermann B. The liver as an immunological organ. Hepatology 2006; 43: S54-62.","DOI":"10.1002\/hep.21060"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB2","unstructured":"2.\u2002 Crispe IN , Dao T , Klugewitz K , et al. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000; 174: 47-62."},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB3","doi-asserted-by":"crossref","unstructured":"3.\u2002 Diehl L , Schurich A , Grochtmann R , et al. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8(+) T cell tolerance. Hepatology 2008; 47: 296-305.","DOI":"10.1002\/hep.21965"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB4","doi-asserted-by":"crossref","unstructured":"4.\u2002 Mehal WZ , Azzaroli F , Crispe IN. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol 2001; 167: 667-73.","DOI":"10.4049\/jimmunol.167.2.667"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB5","doi-asserted-by":"crossref","unstructured":"5.\u2002 Warren A , Le Couteur DG , Fraser R , et al. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 2006; 44: 1182-90.","DOI":"10.1002\/hep.21378"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB6","doi-asserted-by":"crossref","unstructured":"6.\u2002 Guy CS , Rankin SL , Wang J , Michalak TI. Hepatocytes can induce death of contacted cells via a perforin-dependent mechanism. Hepatology 2008; 47: 1691-701.","DOI":"10.1002\/hep.22228"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB7","doi-asserted-by":"crossref","unstructured":"7.\u2002 Guy CS , Wang J , Michalak TI. Hepatocytes as cytotoxic effector cells can induce cell death by CD95 ligand-mediated pathway. Hepatology 2006; 43: 1231-40.","DOI":"10.1002\/hep.21201"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB8","doi-asserted-by":"crossref","unstructured":"8.\u2002 Guidotti LG , Ishikawa T , Hobbs MV , et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36.","DOI":"10.1016\/S1074-7613(00)80295-2"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB9","doi-asserted-by":"crossref","unstructured":"9.\u2002 Kakimi K , Guidotti LG , Koezuka Y , Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000; 192: 921-30.","DOI":"10.1084\/jem.192.7.921"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB10","doi-asserted-by":"crossref","unstructured":"10.\u2002 Hodgson PD , Michalak TI. Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 2001; 34: 1049-59.","DOI":"10.1053\/jhep.2001.29004"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB11","doi-asserted-by":"crossref","unstructured":"11.\u2002 Hodgson PD , Grant MD , Michalak TI. Perforin and Fas\/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis. Clin Exp Immunol 1999; 118: 63-70.","DOI":"10.1046\/j.1365-2249.1999.01010.x"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB12","doi-asserted-by":"crossref","unstructured":"12.\u2002 Churchill ND , Michalak TI. Woodchuck hepatitis virus hepatocyte culture models. Methods Mol Med 2004; 96: 175-87.","DOI":"10.1385\/1-59259-670-3:175"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB13","doi-asserted-by":"crossref","unstructured":"13.\u2002 Wang J , Michalak TI. Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon. J Virol 2006; 80: 8541-53.","DOI":"10.1128\/JVI.00830-06"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB14","doi-asserted-by":"crossref","unstructured":"14.\u2002 Coffin CS , Pham TN , Mulrooney PM , et al. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection. Hepatology 2004; 40: 1053-61.","DOI":"10.1002\/hep.20419"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB15","doi-asserted-by":"crossref","unstructured":"15.\u2002 Michalak TI , Pardoe IU , Coffin CS , et al. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999; 29: 928-38.","DOI":"10.1002\/hep.510290329"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB16","doi-asserted-by":"crossref","unstructured":"16.\u2002 Michalak TI , Mulrooney PM , Coffin CS. Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J Virol 2004; 78: 1730-8.","DOI":"10.1128\/JVI.78.4.1730-1738.2004"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB17","doi-asserted-by":"crossref","unstructured":"17.\u2002 Wang J , Michalak TI. Comparison of biological activity of recombinant woodchuck interferon gamma and tumor necrosis factor alpha produced in baculovirus and Escherichia coli expression systems. Cytokine 2005; 30: 22-34.","DOI":"10.1016\/j.cyto.2004.11.006"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB18","doi-asserted-by":"crossref","unstructured":"18.\u2002 Guy CS , Mulrooney-Cousins PM , Churchill ND , Michalak TI. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol 2008; 82: 8579-91.","DOI":"10.1128\/JVI.01022-08"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB19","doi-asserted-by":"crossref","unstructured":"19.\u2002 Wang J , Gujar SA , Cova L , Michalak TI. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity. J Virol 2007; 81: 903-16.","DOI":"10.1128\/JVI.01537-06"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB20","doi-asserted-by":"crossref","unstructured":"20.\u2002 Thimme R , Wieland S , Steiger C , et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68-76.","DOI":"10.1128\/JVI.77.1.68-76.2003"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB21","doi-asserted-by":"crossref","unstructured":"21.\u2002 Sitia G , Isogawa M , Iannacone M , et al. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest 2004; 113: 1158-67.","DOI":"10.1172\/JCI200421087"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB22","doi-asserted-by":"crossref","unstructured":"22.\u2002 Luo KX , Zhu YF , Zhang LX , et al. In situ investigation of Fas\/FasL expression in chronic hepatitis B infection and related liver diseases. J Viral Hepat 1997; 4: 303-7.","DOI":"10.1046\/j.1365-2893.1997.00053.x"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB23","doi-asserted-by":"crossref","unstructured":"23.\u2002 Huang L , Soldevila G , Leeker M , et al. The liver eliminate T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994; 1: 741-9.","DOI":"10.1016\/S1074-7613(94)80016-2"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB24","doi-asserted-by":"crossref","unstructured":"24.\u2002 Samlowski WE , Spangrude GJ , Daynes RA. Studies on the liver sequestation of lymphocytes bearing membrane-associated galactose-terminal glycoconjugates: reversal with agents that effectively compete for the asialoglycoprotein receptor. Cell Immunol 1984; 88: 309-22.","DOI":"10.1016\/0008-8749(84)90164-3"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB25","doi-asserted-by":"crossref","unstructured":"25.\u2002 Signore A , Annovazzi A , Gradini R , Liddi R , et al. Fas and Fas ligand-mediated apoptosis and its role in autoimmune diabetes. Diabetes Metab Rev 1998; 14: 197-206.","DOI":"10.1002\/(SICI)1099-0895(1998090)14:3<197::AID-DMR213>3.0.CO;2-G"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB26","doi-asserted-by":"crossref","unstructured":"26.\u2002 Pearl-Yafe M , Yolcu ES , Yaniv I , et al. The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation. Bioessays 2006; 28: 211-22.","DOI":"10.1002\/bies.20356"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB27","doi-asserted-by":"crossref","unstructured":"27.\u2002 Matloubian M , Suresh M , Glass A , et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol 1999; 73: 2527-36.","DOI":"10.1128\/JVI.73.3.2527-2536.1999"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB28","doi-asserted-by":"crossref","unstructured":"28.\u2002 Siegel RM , Chan FK , Chun HJ , Lenardo MJ. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 2000; 1: 469-74.","DOI":"10.1038\/82712"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB29","doi-asserted-by":"crossref","unstructured":"29.\u2002 Suzuki I , Fink PJ. The dual functions of Fas ligand in the regulation of peripheral CD8+ and CD4+ T cells. Proc Natl Acad Sci USA 2000; 97: 1707-12.","DOI":"10.1073\/pnas.97.4.1707"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB30","doi-asserted-by":"crossref","unstructured":"30.\u2002 Desbarats J , Newell MK. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 2000; 6: 920-3.","DOI":"10.1038\/78688"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB31","doi-asserted-by":"crossref","unstructured":"31.\u2002 Pham BN , Martinot-Peignoux M , Valla D , et al. Differential expression of perforin and granzyme B in the liver of patients with chronic hepatitis C. Hum Pathol 2003; 34: 770-7.","DOI":"10.1016\/S0046-8177(03)00244-2"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB32","doi-asserted-by":"crossref","unstructured":"32.\u2002 Salcedo TW , Azzoni L , Wolf SF , Perussia B. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 1993; 151: 2511-20.","DOI":"10.4049\/jimmunol.151.5.2511"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB33","doi-asserted-by":"crossref","unstructured":"33.\u2002 Shresta S , Russell JH , Ley TJ. Mechanisms responsible for granzyme B-independent cytotoxicity. Blood 1997; 89: 4085-91.","DOI":"10.1182\/blood.V89.11.4085"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB34","doi-asserted-by":"crossref","unstructured":"34.\u2002 Iken K , Huang L , Bekele H , Schmidt EV , Koziel MJ. Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction. Virology 2006; 346: 363-72.","DOI":"10.1016\/j.virol.2005.11.017"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB35","doi-asserted-by":"crossref","unstructured":"35.\u2002 Lee MO , Choi YH , Shin EC , et al. Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. J Hepatol 2002; 37: 380-6.","DOI":"10.1016\/S0168-8278(02)00181-2"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB36","doi-asserted-by":"crossref","unstructured":"36.\u2002 Lara-Pezzi E , Majano PL , Gomez-Gonzalo M , et al. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology 1998; 28: 1013-21.","DOI":"10.1002\/hep.510280416"},{"key":"10.1111\/j.1478-3231.2009.02168.x-BIB37","doi-asserted-by":"crossref","unstructured":"37.\u2002 Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 651-60.","DOI":"10.1007\/s005350170027"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02168.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2009.02168.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T14:14:05Z","timestamp":1685196845000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02168.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02168.x","relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}